Search results
Two Covid Theories
New York Times· 6 days agoWas the pandemic started by a lab leak or by natural transmission? The origin of the Covid virus remains the pandemic’s biggest mystery. Did the virus...
MD Anderson Research Highlights: EHA 2024 Special | Newswise
Newswise· 7 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research, and prevention. Thes
World leaders back just peace for Ukraine, eye eventual Russia talks
KTBS Shreveport· 3 days agoMore than two years after Russia invaded, leaders and top officials from more than 90 states spent...
Milestone for Biotest: US Approval for Innovative Immunoglobulin Yimmugo
NewMediaWire via Yahoo Finance· 2 days agoFDA approval secures significant future sales and earnings growth through entry into the world's...
ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory...
Morningstar· 6 days agoThese data from MagnetisMM-3 will be presented during a poster session (#932) at the European Hematology Association (EHA) Hybrid Congress in Madrid, Spain, from June 13-16 ...
Visa-free policy helps promote global exchanges
China Daily· 2 days agoAguilar's frequent trips to China have been propelled by a 2018 agreement, signed during President Xi Jinping's visit to Spain, that allowed the European country to export ...
World Leaders Back Just Peace For Ukraine, Eye Eventual Russia Talks
International Business Times· 3 days agoMore than two years after Russia invaded, leaders and top officials from more than 90 states spent the weekend at a Swiss mountainside resort for a two-day summit dedicated to resolving the ...
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology...
Digital Journal· 6 days agoTUS Monotherapy and TUS+Venetoclax (VEN) Doublet Therapy Show Broad Clinical Activity and Strong Safety Data in relapsed or refractory (R/R) Acute Myeloid Leukemia (AML) and ...
This is why character matters in the presidential race | Letters
Tampa Bay Times· 6 days agoWith an election coming up, it is typical for politicians to embellish, exaggerate and flat out...
Genentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People...
Morningstar· 5 days agoGenentech’s Phase III STARGLO Study Demonstrates Columvi Significantly Extends Survival in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma – The study met its primary endpoint of overall survival with a 41% reduction in the risk of
